
معرفی
Dr. Gal Finer serves as a pediatric nephrologist at Ann & Robert H. Lurie Children's Hospital of Chicago and holds an Assistant Professor position in the Department of Pediatrics at Northwestern University Feinberg School of Medicine. Her clinical expertise centers on rare genetic kidney disorders, kidney development, and congenital anomalies of the kidney and urinary tract (CAKUT).
Her educational journey includes:
- MD from Ben Gurion University, Israel (1997)
- PhD from Ben Gurion University, Israel (2007)
- Pediatrics Residency at Soroka University Medical Center (2004) and Northwestern University McGaw Medical Center (2015)
- Pediatric Nephrology Fellowship at Northwestern University McGaw Medical Center (2010)
Dr. Finer's research employs cutting-edge single-cell and multi-omic methodologies including scRNA-seq and scATAC-seq to investigate molecular mechanisms in kidney development. Her work bridges basic science with clinical applications, particularly in transcription factor regulation (TCF21) and stromal development pathways. She actively leads initiatives to establish specialized clinics for rare conditions like Bardet-Biedl syndrome, emphasizing translational approaches to improve diagnostic frameworks and patient-centered care for congenital kidney disorders.
Her publication record demonstrates consistent focus on developmental mechanisms in renal physiology, with increasing emphasis on chromatin accessibility and transcriptional regulation since 2022. The research trajectory shows progression from molecular characterization of kidney stroma to direct clinical applications in rare genetic disorders.
Professional recognition includes:
- Resident Teacher Award, Department of Pediatrics, Feinberg School of Medicine (2014)
- Trainee Research Award in Basic Science, American Association of Pediatric Nephrology (2010)
- Research Scholar Day, Ann & Robert Lurie Children's Memorial Hospital (2010)
Dr. Finer maintains active professional engagement through the American Society of Pediatric Nephrology Research Committee (2018-present) and multiple societies including the American Society of Nephrology and International Pediatric Nephrology Association. She has no disclosed external professional relationships for 2024. Her institutional affiliations include the Feinberg Cardiovascular and Renal Research Institute – Center for Kidney Research and Therapeutics and the Simpson Querrey Institute for Epigenetics, where she contributes to multidisciplinary teams advancing kidney disease research.



